Tristan Montier

Dr. Tristan Montier

UMR INSERM 1078, Université de Brest, Faculté de médecine et des sciences de la santé, 22 rue camille Desmoulins, F-29609 Brest, France ; Brest University Teaching Hospital, Service de Génétique Médicale et Biologie de la Reproduction, Centre de Référence des Maladies Rares, 2 avenue du Maréchal Foch, 29200 Brest, France
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2021 in Pharmaceutics
Verified
Journal Article
Open access
RYRaphaëlle Youf
Raphaëlle Youf
MMMax Müller
Max Müller
ABAli Balasini
Ali Balasini
FTFranck Thétiot
Franck Thétiot
MMMareike Müller
Mareike Müller
TGTony LE GALL
Tony LE GALL
Antimicrobial photodynamic therapy (aPDT) has become a fundamental tool in modern therapeutics, notably due to the expanding versatility of photosensitizers (PSs) and the numerous possibilities to combine aPDT with other antimicrobial treatments to combat localized infections. After revisiting the basic principles of aPDT, this review first highlights the current state of the art of curative or preventive aPDT applications with relevant clinical trials. In addition, the most recent developments in photochemistry and photophysics as well as advanced carrier systems in the context of aPDT are provided, with a focus on the latest generations of efficient and versatile PSs and the progress towards hybrid-multicomponent systems. In particular, deeper insight into combinatory aPDT approaches is afforded, involving non-radiative or other light-based modalities. Selected aPDT perspectives are outlined, pointing out new strategies to target and treat microorganisms. Finally, the review works out the evolution of the conceptually simple PDT methodology towards a much more sophisticated, integrated, and innovative technology as an important element of potent antimicrobial strategies.

1 October 2008 in Current Gene Therapy
Verified
Journal Article
Closed access
PDF file
Tristan MontierTristan Montier
Tristan Montier
TBThierry Benvegnu
Thierry Benvegnu
PJPaul-Alain Jaffres
Paul-Alain Jaffres
JYJean-Jacques Yaouanc
Jean-Jacques Yaouanc
PLPierre Lehn
Pierre Lehn
Over the last several years, various gene delivery systems have been developed for gene therapy applications. Although viral vector-based gene therapy has led to the greatest achievements in animal and human studies, synthetic nonviral vectors have also been developed as they offer several advantages over viral systems, including lower immunogenicity and greater nucleic acid packaging capacity. Nevertheless, the transfection efficiency of the current non-viral gene carriers still needs to be improved, especially as regards direct in vivo transfection. In particular, cationic lipid/nucleic acid complexes (termed lipoplexes) have been the subject of intensive investigation with a view to optimize their performance and to better understand their mechanisms of action, and consequently to design new approaches to overcome the critical barriers of cationic liposome-mediated gene delivery. A possible strategy may rely on considering the membrane constituents and properties of the vast variety of living organisms as a source of inspiration for the design of biocompatible, nontoxic and effective novel artificial liposomal systems. Thus, the present forward-looking review provides an overview of the progress already made during the last years in the field of cationic lipid-mediated gene transfection and also focuses on a series of novel bio-inspired lipids for both in vitro and in vivo gene transfection.

1 November 2004 in Trends in Biotechnology
Verified
Journal Article
Closed access
Tristan MontierTristan Montier
Tristan Montier
PDP. Delépine
P. Delépine
CPC. Pichon
C. Pichon
CFC. Férec
C. Férec
DPD.J. Porteous
D.J. Porteous
PMPatrick Midoux
Patrick Midoux

1 December 2017 in Pharmacological Research
Verified
Journal Article
Closed access
PRPauline Resnier
Pauline Resnier
NGNatacha Galopin
Natacha Galopin
YSYann Sibiril
Yann Sibiril
ACAnne Clavreul
Anne Clavreul
JCJérôme Cayon
Jérôme Cayon
CPCatherine Passirani
Catherine Passirani

9 August 2019 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
BFB. Le Floch
B. Le Floch
HBH. Bastiaens
H. Bastiaens
JRJ. Y. Le Reste
J. Y. Le Reste
HLHeidrun Lingner
Heidrun Lingner
RHR. Hoffman
R. Hoffman
LPLieve Peremans
Lieve Peremans
General Practice (GP) seems to be perceived as less attractive throughout Europe. Most of the policies on the subject focused on negative factors. An EGPRN research team from eight participating countries was created in order to clarify the positive factors involved in appeals and retention in GP throughout Europe. The objective was to explore the positive factors supporting the satisfaction of General Practitioners (GPs) in clinical practice throughout Europe. Qualitative study, employing face-to-face interviews and focus groups using a phenomenological approach. The setting was primary care in eight European countries: France, Belgium, Germany, Slovenia, Bulgaria, Finland, Poland and Israel. A thematic qualitative analysis was performed following the process described by Braun and Clarke. Codebooks were generated in each country. After translation and back translation of these codebooks, the team clarified and compared the codes and constructed one international codebook used for further coding. A purposive sample of 183 GPs, providing primary care to patients in their daily clinical practice, was interviewed across eight countries. The international codebook included 31 interpretative codes and six themes. Five positive themes were common among all the countries involved across Europe: the GP as a person, special skills needed in practice, doctor-patient relationship, freedom in the practice and supportive factors for work-life balance. One theme was not found in Poland or Slovenia: teaching and learning. This study identified positive factors which give GPs job satisfaction in their clinical practice. This description focused on the human needs of a GP. They need to have freedom to choose their working environment and to organize their practice to suit themselves. In addition, they need to have access to professional education so they can develop specific skills for General Practice, and also strengthen doctor-patient relationships. Stakeholders should consider these factors when seeking to increase the GP workforce.

3 June 2015 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
NBNawal Belmadi
Nawal Belmadi
PMPatrick Midoux
Patrick Midoux
PLPascal Loyer
Pascal Loyer
CPCatherine Passirani
Catherine Passirani
CPChantal Pichon
Chantal Pichon
Tristan MontierTristan Montier
Tristan Montier